These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2856900)

  • 1. Kinetic determination of blood coagulation Factor XIII in plasma.
    Muszbek L; Polgár J; Fésüs L
    Clin Chem; 1985 Jan; 31(1):35-40. PubMed ID: 2856900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A modified, optimized kinetic photometric assay for the determination of blood coagulation factor XIII activity in plasma.
    Kárpáti L; Penke B; Katona E; Balogh I; Vámosi G; Muszbek L
    Clin Chem; 2000 Dec; 46(12):1946-55. PubMed ID: 11106327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microtiter assay for measurement of factor XIII activity in plasma.
    Dempfle CE; Harenberg J; Hochreuter K; Heene DL
    J Lab Clin Med; 1992 May; 119(5):522-8. PubMed ID: 1349910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorimetric assay of blood coagulation factor XIII in plasma.
    Lee KN; Birckbichler PJ; Patterson MK
    Clin Chem; 1988 May; 34(5):906-10. PubMed ID: 2897256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A microtiter assay for factor XIII using fibrinogen and biotinylcadaverine as substrates.
    Song YC; Sheng D; Taubenfeld SM; Matsueda GR
    Anal Biochem; 1994 Nov; 223(1):88-92. PubMed ID: 7695107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of factor XIII activity in plasma.
    Katona É; Pénzes K; Molnár É; Muszbek L
    Clin Chem Lab Med; 2012 Feb; 50(7):1191-202. PubMed ID: 22850052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ammonia production during clot retraction and its use in assay of fibrinoligase.
    Mousli S; Wakid NW
    Clin Chem; 1977 Sep; 23(9):1739-43. PubMed ID: 890918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium and the assays of human plasma clotting factor XIII.
    Cooke RD; Holbrook JJ
    Biochem J; 1974 Jul; 141(1):71-8. PubMed ID: 4455208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A photometric assay for blood coagulation factor XIII.
    Fickenscher K; Aab A; Stüber W
    Thromb Haemost; 1991 May; 65(5):535-40. PubMed ID: 1871715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of factor XIII activity and of factor XIII inhibitors using an ammonium-sensitive electrode.
    Hellstern P; Schilz K; von Blohn G; Wenzel E
    Thromb Haemost; 1983 Aug; 50(2):563-6. PubMed ID: 6138878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural features of glutamine substrates for human plasma factor XIIIa (activated blood coagulation factor XIII).
    Gorman JJ; Folk JE
    J Biol Chem; 1980 Jan; 255(2):419-27. PubMed ID: 6101325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium-induced dissociation of human plasma factor XIII and the appearance of catalytic activity.
    Cooke RD
    Biochem J; 1974 Sep; 141(3):683-91. PubMed ID: 4463958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimisation of a new continuous UV assay for the determination of blood coagulation factor XIII activity in human plasma.
    Heins M; Fahron U; Withold W; Rick W
    Eur J Clin Chem Clin Biochem; 1994 Jun; 32(6):479-83. PubMed ID: 7918847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative pathways for the activation of factor XIII.
    McDonagh J; McDonagh RP
    Br J Haematol; 1975 Aug; 30(4):465-77. PubMed ID: 1201228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
    Siebenlist KR; Meh DA; Mosesson MW
    Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of blood coagulation Factor XIIIa formation in plasma containing glycyl-L-prolyl-L-arginyl-L-proline.
    Miraglia CC; Greenberg CS
    Anal Biochem; 1985 Jan; 144(1):165-71. PubMed ID: 2858990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A specific, fluorescent activity staining procedure applied to plasma and red blood cells in congenital factor XIII deficiency.
    Henriksson P; Stenberg P; Nilsson IM; Rasovic N; Kezic J; Stenbjerg S
    Br J Haematol; 1980 Jan; 44(1):141-7. PubMed ID: 6155132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fluorescent spot test for coagulation factor XIII.
    Coggan M; Board PG
    Anal Biochem; 1984 Mar; 137(2):402-4. PubMed ID: 6731823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. b-chains prevent the proteolytic inactivation of the a-chains of plasma factor XIII.
    Mary A; Achyuthan KE; Greenberg CS
    Biochim Biophys Acta; 1988 Sep; 966(3):328-35. PubMed ID: 2901275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.